Oric Pharmaceuticals ORIC
NASDAQ ORIC
$12.20 -0.32 (-2.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oric Pharmaceuticals (ORIC) Selling, General & Administrative (2019 - 2026)

Updated

Oric Pharmaceuticals' Selling, General & Administrative came in at $9 million for Q2 2026, up 5.7% from $8.52 million a year earlier and up 10.0% from the prior quarter.

Analysis

Oric Pharmaceuticals (ORIC) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Oric Pharmaceuticals reported Selling, General & Administrative of $33.78 million, up 7.9% year-over-year; for FY2025, it came in at $33.19 million, up 15.1% from FY2024.

  • Selling, General & Administrative has increased in each of the last seven years, with a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $28.82 million in FY2024 (+12.6%), $25.61 million in FY2023 (+2.1%), $25.09 million in FY2022 (+14.0%) and $22.01 million in FY2021 (+64.0%).
  • The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q1 2019.
  • Year-over-year, Selling, General & Administrative has increased for 12 consecutive quarters, with growth averaging 11.3% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 46.2%), and the weakest in Q2 2023 (a decline of 9.6%).
  • Business Quant data shows ORIC's Selling, General & Administrative at $8.18 million (Q1 2026), $8.7 million (Q4 2025) and $7.9 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Oric Pharmaceuticals 1.30 Bn 1.30 Bn - 9.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.00 Mn
Mar 31, 2026 8.18 Mn
Dec 31, 2025 8.70 Mn
Sep 30, 2025 7.90 Mn
Jun 30, 2025 8.52 Mn
Mar 31, 2025 8.08 Mn
Dec 31, 2024 7.60 Mn
Sep 30, 2024 7.12 Mn
Jun 30, 2024 7.08 Mn
Mar 31, 2024 7.03 Mn
Dec 31, 2023 6.95 Mn
Sep 30, 2023 6.29 Mn
Jun 30, 2023 6.21 Mn
Mar 31, 2023 6.16 Mn
Dec 31, 2022 5.82 Mn
Sep 30, 2022 5.97 Mn
Jun 30, 2022 6.86 Mn
Mar 31, 2022 6.43 Mn
Dec 31, 2021 6.06 Mn
Sep 30, 2021 5.56 Mn
API Access

Oric Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ORIC&period=max&api_key=YOUR_API_KEY